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In this article we show that the paramyxovirus SV5 is a poor inducer of interferon- (IFN-). This inefficient induction is a
consequence of the expression of an intact viral V protein. In the absence of the viral V protein cysteine-rich C-terminal
domain, IFN- mRNA is strongly induced and the transcription factors NF-B and IRF-3 are activated significantly. The V
protein can work in isolation from SV5 to block intracellular dsRNA signaling. The mechanism of block to dsRNA signaling
is distinct from that previously observed for blocking IFN signaling in that proteolysis of candidate factors cannot be
detected, and furthermore, the respective blocks require distinct protein domains. Blocking of the induction of IFN- by
dsRNA requires the C-terminal cysteine-rich domain, a feature that is highly conserved among paramyxoviruses. WeINTRODUCTION
The type I interferons (IFNs) are secreted polypeptides
that act in a pleiotropic manner to limit viral replication
and spread (reviewed by Biron and Sen, 2001). In fibro-
blastoid cells such as bronchial epithelia the product of
the single IFN- gene is directly induced in response to
viral infection and IFN- feeds back onto cells in an
autocrine fashion to set up a state that permits induction
of the multigene IFN- family if infection persists (re-
viewed by Taniguchi et al., 2001). Since most viruses are
capable of inducing IFN- to some extent, it is generally
assumed that the common inducer is intracellular dou-
ble-stranded RNA (dsRNA) provided by the viral genome
itself or formed as a result of replication or convergent
transcription of viral genomes (reviewed by Jacobs and
Langland, 1996).
To establish even transient infections in vivo, viruses
must be able to evade the IFN response. It is well
established that viruses can block the activities of en-
zymes involved in the IFN response; more recently it has
become clear that many viruses block IFN signaling in a
variety of ways (reviewed in Goodbourn et al., 2000). For
example, the Rubulavirus genus, including simian virus 5
(SV5) and human parainfluenza virus 2 (hPIV2) of the
Paramyxoviridae, directs the proteolytic degradation of
1 Present address: Department of Veterinary Science, Penn State
University, University Park, PA 16802.33members of the STAT family of transcription factors in a
species-specific manner. Thus, SV5 infections lead to the
degradation of STAT1 in human cells but not in mouse
cells (Didcock et al., 1999a,b; Parisien et al., 2002),
whereas hPIV2 infection leads to the degradation of
STAT2 in human cells (Young et al., 2000; Parisien et al.,
2001; Nishio et al., 2001; Andrejeva et al., 2002). Other
paramyxoviruses, for example the Respirovirus Sendai
virus, interfere with IFN signaling without necessarily
causing STAT degradation (Young et al., 2000; reviewed
in Gotoh et al., 2001).
Viruses might also evade the IFN system by encoding
mechanisms that limit the production of IFN. Although
there is only a limited amount of information available on
the molecular mechanisms of this process, there ap-
pears to be a considerable spectrum in the levels of IFN
induced by individual viruses (reviewed in Marcus, 1983),
suggesting that viruses have evolved mechanisms to at
least limit the yield of IFN. In the case of influenza A
virus, the NS1 protein may play such a role. This protein
is a dsRNA-binding protein that may limit the amount of
inducer presented to the cell; thus NS1 can block acti-
vation of NF-B by synthetic dsRNA (Wang et al., 2000),
while an influenza strain lacking the NS1 gene induces
NF-B, IRF-3, and IFN- (Talon et al., 2000).
The induction of IFN- expression by viral infection
has been the subject of intensive research and occurs
primarily at the level of transcriptional initiation. The
IFN- promoter consists of four positive regulatory do-demonstrate that the V proteins from other paramyxovirus
of IFN- during infection may be a general property of par
2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (44)-0208-725-2992. E-mail: s.goodbourn@sghms.ac.uk.
doi:10.1006/viro.2002.1737equivalent functions and speculate that limiting the yield
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mains (PRDs) that contribute to the magnitude of induc-
tion with each PRD being the target for a distinct, inde-
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pendently activated, transcription factor (reviewed in
Goodbourn et al., 2000; see Fig. 3A). PRD II is bound and
activated by NF-B (Lenardo et al., 1989; Visvanathan
and Goodbourn, 1989) and PRD IV is bound and acti-
vated by either ATF-2 homodimers or a heterodimer of
ATF-2/c-Jun (Du and Maniatis, 1992; Du et al., 1993). The
situation with PRD I and PRD III is more complicated;
these elements are related at the DNA sequence level
and both bind to members of the interferon regulatory
factor (IRF) family. It remains unclear whether activation
through PRD I/PRD III is restricted to a specific IRF
protein, but recent observations indicate that IRF-3 acti-
vation is especially important (Juang et al., 1998; Lin et
al., 1998; Ronco et al., 1998; Sato et al., 1998; Schafer et
al., 1998; Wathelet et al., 1998; Weaver et al., 1998; Yo-
neyama et al., 1998). The individually activated transcrip-
tion factors that bind to PRDs I–IV are assembled in a
cooperative manner on the IFN- promoter in a multipro-
tein complex, called the enhanceosome, that also in-
cludes the “architectural factor” HMG-I:Y (reviewed by
Merika and Thanos, 2001).
The signaling pathways between the detection of in-
tracellular dsRNA and the activation of transcription fac-
tors are poorly understood, although it is established that
the dsRNA-dependent protein kinase (PKR) plays an im-
portant role (reviewed by Williams, 2001). PKR activates
the IKK subunit of the multicomponent IB kinase (Chu
et al., 1999; Zamanian-Daryoush et al., 2000) in a manner
that may not require the PKR catalytic activity (Ishii et al.,
2001); IB kinase phosphorylates IB, which in turn be-
comes ubiquitinated by an E3 ubiquitin ligase and tar-
geted to proteasomes for degradation. Once the inhibi-
tory IB is destroyed, the associated NF-B is freed from
restraint and can enter the nucleus and activate tran-
scription (reviewed in Israel, 2000). Activation of PKR is
also important in the rise in IRF-1 levels that are seen in
response to viral infection or exposure to synthetic
dsRNA (Kumar et al., 1997), and in the activation of the
PRD IV-binding ATF-2 complexes through the intermedi-
acy of MAP kinases (Chu et al., 1999; Iordanov et al.,
2000b). However, it has recently been shown that NF-B
may also be activated in response to dsRNA by an
uncharacterized PKR-independent pathway (Iordanov et
al., 2000a). Thus there may be at least two distinct intra-
cellular dsRNA signaling pathways. Furthermore, al-
though the relocalization of IRF-3 from the cytoplasm to
the nucleus in response to viral infection or synthetic
dsRNA requires a cellular kinase, current experimental
data are consistent with this kinase being something
other than PKR (Smith et al., 2001; Servant et al., 2001).
In this article we show that the product of the V gene
of SV5 plays an essential role in limiting the induction of
IFN- mRNA during viral infection. A recombinant SV5
virus that expresses a V protein lacking the unique C-
terminus induces significant levels of IFN- mRNA and
activates NF-B and IRF-3. These proteins are not de-
graded during infection by wild-type SV5, and hence, the
product of the V gene can affect both arms of the IFN-
mediated innate immune response using distinct mech-
anisms. Unlike the targeted degradation of STAT1 which
requires both N- and C-terminal epitopes, only the cys-
teine-rich region of the V protein is required to block
dsRNA signaling. This region is highly conserved among
paramyxoviruses, and we show that the V gene products
of hPIV2 and Sendai virus also block IFN- induction;
these observations suggest that limiting the yield of
IFN- during infection may be a general property of
paramyxoviruses.
RESULTS
Efficient induction of IFN- by SV5 lacking
the C-terminus of the V protein
We have reported previously that SV5 infection in-
duces the expression of IFN- in mouse and human cell
lines (Didcock et al., 1999a). To assess the relative effi-
ciency of induction by SV5 with that of other known
inducers, we examined the production of IFN- mRNA in
a number of cell lines. Figure 1A shows an experiment
performed using MG-63 cells (a human osteosarcoma
cell line widely used as a potent IFN- producer). Al-
though wild-type (wt) SV5 (W3)-infection induces IFN-
mRNA, the levels produced even under optimum condi-
tions [multiplicity of infection (m.o.i.)  5, 18 h postinfec-
tion (p.i.); Lanes 1 to 4] are barely detectable in compar-
ison to that seen by the addition of the synthetic dsRNA
[poly(I)-poly(C)] to the culture medium (Lane 7). To com-
pare induction of IFN- by wt SV5 (W3) with well-char-
acterized inducers, we analyzed the behavior of Sendai
virus and Newcastle disease virus (NDV) in MG-63 cells.
Figure 1A (Lanes 8 and 9) shows that both of these
viruses induce IFN- at least as well as poly(I)-poly(C)
and considerably better than SV5 at the same input m.o.i.
The Sendai virus stock used in the experiment shown in
Lane 9 was prepared by inoculation of 10-day-old em-
bryonated chickens eggs with a high dilution of viral
stock. However, the efficient induction of IFN- normally
observed with Sendai virus is associated with DI parti-
cles that are generated by serial passage in embryo-
nated chicken eggs at low dilutions (von Magnus,
1951a,b; Johnston, 1981). When Sendai virus was pre-
pared in this way, the induction of IFN- was consider-
ably greater than the high dilution inoculum stock of
Sendai virus at an equivalent m.o.i. (Fig. 1A, compare
Lanes 10 and 9). The relatively poor induction by SV5 in
comparison to dsRNA, NDV, and the optimized Sendai
virus preparation was also seen in human fibroblast
2fTGH cells, human embryonic kidney (293) cells, or
mouse BALB/c cells (data not shown). These results
indicate that SV5 and certain stocks of Sendai virus are
intrinsically poor inducers of IFN- in human fibroblas-
toid cell lines.
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Since we had previously shown that the V protein of
SV5 was capable of blocking signaling in response to
IFN (Didcock et al., 1999b), we next investigated whether
SV5 engineered to express a V gene product that is
truncated so as to lack the C-terminal cysteine-rich do-
main (rSV5VC—see accompanying article, He et al.,
2002) was able to induce IFN- more efficiently than
wild-type SV5. Figure 1B shows that infection of MG-63
cells with the W3 strain of SV5 causes a weak induction
of IFN- mRNA that is barely detectable at 18 h p.i.
(Lanes 1–4); by contrast, infection with rSV5VC at an
equivalent m.o.i. strongly induces IFN- mRNA at the
earliest time point examined (12 h p.i.; Fig. 1B, Lanes
5–7). A similarly enhanced induction of IFN- mRNA by
rSV5VC relative to the W3 strain was seen in human
2fTGH cells (see Fig. 2A) and mouse BALB/c cells (data
not shown). These data indicate that SV5 which lacks an
intact V protein either produces an inducer of IFN- not
made by the wild-type virus and/or that the SV5 V protein
is a potent inhibitor of IFN- mRNA induction. It is also
noteworthy that unlike the species-specificity of the SV5
V protein with respect to blocking IFN signaling (Didcock
et al., 1999b; Young et al., 2001; Parisien et al., 2002)
expression of the intact SV5 V protein limits the produc-
tion of IFN- mRNA in both human and mouse cells.
We previously reported important differences in the
ability of two closely related canine isolates of SV5,
termed CPI and CPI, to block IFN signaling (Chatzi-
andreou et al., 2002). CPI blocks IFN signaling by
targeting STAT1 for degradation, whereas CPI does
not; this difference is the result of three amino acid
substitutions in the common V/P N-terminal domain. Al-
though these viruses exhibit indistinguishable growth in
cells that cannot produce type I IFN it would be expected
that in cells that can produce IFN, the replication of the
CPI strain would be impaired as a result of IFN sensi-
tivity. Surprisingly, we found that CPI infections were
only cleared slowly in the latter unless the cells were
treated with type I IFN (CPI infections which block IFN
responses were resistant to exogenous IFN; Chatzian-
dreou et al., 2002). These results can be explained if
CPI and CPI strains are poor IFN- inducers. To test
this directly, we compared the IFN- induction profile by
CPI and CPI. Figure 1C shows that both CPI (Lanes
5–7) and CPI (Lanes 8–10) are poor inducers in MG-63
cells when compared to rSV5VC (Lane 12), NDV, and
the optimized Sendai virus preparation (data not shown),
although they are slightly more efficient inducers than
SV5 W3 (Lanes 2–4). The fact that little or no difference is
seen in the early phase of IFN- induction by CPI and
CPI shows that the substitutions in the CPI V protein
that alter the ability to block IFN signaling are distin-
guishable from V protein functions that block IFN- in-
duction. It is interesting to note that at later periods in
infection (21 h p.i.), CPI begins to become a better
inducer than CPI (Fig. 1C, compare Lanes 7 and 10).
Although IFN- induction occurs without the need for de
novo protein synthesis, the yield is enhanced by a pos-
itive autoregulation loop that can involve the activation of
ISGF3 or IRF-1 by IFN (Yoneyama et al., 1996), or the
induction of synthesis of IRF-7, which is subsequently
activated by viral infection (reviewed by Taniguchi et al.,
2001). The ability of the CPI virus to block IFN signaling
would prevent this virus from showing the amplification
of IFN- production seen with CPI and thus produce
the observed differences at later time points.
Limited amounts of the V protein of SV5 (350 mole-
cules) enter the target cell as part of the virion (Paterson
et al., 1995). We were therefore interested to see whether
small amounts of SV5 V protein would be sufficient to
block IFN- induction, as seen for the degradation of
STAT1 and the inhibition of IFN signaling, and whether
the induction of IFN- seen in rSV5VC-infected cells
could be blocked by expressing the V protein in trans.
Coinfection of 2fTGH cells by wt SV5 (W3) and rSV5VC
did not lead to a suppression of IFN- induction (Fig. 2A,
Lanes 1–6), perhaps suggesting that the V protein cannot
FIG. 1. SV5 is a poor inducer of IFN-. The human osteosarcoma cell
line, MG-63, was infected with viruses or treated with synthetic dsRNA,
as indicated, and the IFN- mRNA levels determined by RNase map-
ping. The mobilities of the IFN- and -actin transcripts (internal con-
trol) are indicated to the right of each panel. (A) Cells were infected with
SV5 (W3) at an m.o.i. of 5 and incubated for 0 (Lane 1), 15 (Lane 2), 18
(Lane 3), or 21 h (Lane 4) at an m.o.i. of 0.5 for 18 h (Lane 5) or at an
m.o.i. of 50 for 18 h (Lane 6). Poly(I)-poly(C) (dsRNA) was added to the
cell-culture media to 100 g/ml for 4 h (Lane 7). NDV (strain Ulster 2c)
was added at an m.o.i. of 5 for 18 h (Lane 8). Sendai virus was added
at an m.o.i. of 5 for 18 h (Lane 9). Sendai virus (thrice passaged at 1 in
10 dilution in embryonated chicken eggs—von Magnus prep, vM3) was
added at an m.o.i. of 5 for 18 h (Lane 10). (B). Cells were infected with
either SV5 (W3) or rSV5VC (VC) at an m.o.i. of 5 and incubated for 0
(Lane 1), 12 (Lanes 2 and 5), 15 (Lanes 3 and 6), or 18 h (Lanes 4 and
7). (C). Cells were infected at an m.o.i. of 5 with either SV5 (W3; 15 h,
Lane 2; 18 h, Lane 3; 21 h, Lane 4), CPI (15 h, Lane 5; 18 h, Lane 6;
21 h, Lane 7), CPI (15 h, Lane 8; 18 h, Lane 8; 21 h, Lane 10), SV5 W3
with a single amino acid change (N100D) in the V protein (18 h, Lane
11), or VC (18 h, Lane 12).
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work in trans, or that rSV5VC induces IFN- sufficiently
fast enough that the limited amount of V protein entering
the cells in wt SV5 (W3) virions is unable to block the
cellular response to SV5 infection. We next infected a
2fTGH cell line that stably expresses the V protein of SV5
(which blocks IFN signaling in these cells) (Andrejeva et
FIG. 2. The V protein of SV5 can block IFN induction by rSV5VC in trans. (A) The human diploid fibroblast cell line, 2fTGH (Lanes 1–6), and a
derivative that stably expresses the SV5 V protein (Lanes 7–12) were infected with SV5 (W3) or rSV5VC (VC) at an m.o.i. of 5, or a mixture of W3
and rSV5VC at the indicated ratios and a total m.o.i. of 5 for 18 h, and the IFN- mRNA levels determined by RNase mapping. The mobilities of the
IFN- and -actin transcripts (internal control) are indicated to the right of each panel. (B) Vero cells were transfected with a reporter for IFN-
promoter activity [pIF(-125)lucter—see Materials and Methods], the -galactosidase expression vector, pJATlac, and either a mammalian expression
plasmid driving the overexpression of the SV5 V protein or a control “empty vector.” Transfected cells were infected with either SV5 (W3) or rSV5VC
(VC) at an m.o.i. of 5 for 18 h and then cell extracts were prepared for reporter gene assays. In each case luciferase activity was corrected to the
-galactosidase activity to normalize for variations in the transfection efficiency. Transfection experiments were repeated at least three times and
averages and error bars are shown. Expression levels are relative to the rSV5VC-infected level of the 125 construct (1.0). (C) Vero cells were
transfected with either pIF(125)lucter as a reporter for IFN- promoter activity or a reporter for type I IFN responsiveness [p(9–
27ISRE)4tk(39)lucter], the -galactosidase expression vector, pJATlac, and a mixture of a mammalian expression plasmid driving the overexpres-
sion of the SV5 V protein and the control empty vector such that the total amount of effector plasmid was kept constant: The amount of SV5 V
expressing plasmid in each transfection is indicated on the x-axis in nanograms. IFN responsiveness was determined by treating cells for 5 h with
1000 IU/ml of IFN. Responsiveness to rSV5VC (VC) was determined by infecting cells an m.o.i. of 5 for 18 h. In each case luciferase activity was
corrected to the -galactosidase activity to normalize for variations in the transfection efficiency. The inducibilities of the reporters in transfections
with no SV5 V expressing plasmid were determined for IFN and rSV5VC (VC), respectively, and set at 100%; samples from transfections containing
SV5 V protein expressing plasmids are given in percentage maximum inducibility compared to this control. Transfection experiments were performed
twice and averages and error bars are shown.
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al., 2002) with the rSV5VC virus. Figure 2A (Lanes 7–12)
shows that these cells are unable to block IFN- induc-
tion by rSV5VC infection. The SV5 V protein expressing
stable cell lines are characterized by levels that are at
least 20-fold lower than that achieved during a viral
infection (Andrejeva et al., 2002), and we note that we
have not succeeded in constructing cell lines that ex-
press high levels of SV5 V protein, suggesting that this
may be toxic to host cells. To determine whether high-
level V protein expression is capable of blocking IFN-
induction by SV5, we examined the ability of overex-
pressed SV5 V protein to block induction by rSV5VC
infection of a luciferase reporter gene under the control
of an IFN- promoter in transient transfections. Figure 2B
shows that induction is significantly inhibited, indicating
that the viral V protein can act in trans to block induction
if expressed to adequate levels. To test further whether
the respective blocks to IFN signaling and IFN induction
are differentially sensitive to expression levels of the SV5
V protein, we compared the effects of increasing levels of
a plasmid expressing SV5 V on the relative inducibilities
of an ISRE reporter by IFN, and of an IFN- promoter
reporter by rSV5VC infection. Figure 2C shows that SV5
V expression inhibits IFN responses by more than 90%
even at the lowest levels tested, whereas inhibition of
induction of the IFN- promoter reporter by rSV5VC
was barely evident at these levels and required higher
levels of expression to achieve a block of greater than
50%. These data suggest that the block to IFN signaling
and the block to IFN- induction are mechanistically
distinct.
NF-B and IRF-3 activation by SV5 lacking full-length
V gene product
Induction of IFN- by viral infection requires the acti-
vation of distinct transcription factors, with considerable
evidence supporting the importance of NF-B and mem-
bers of the IRF family as the key transcription factors
(see Introduction). To establish the requirement for these
factors for induction of IFN- by rSV5VC and to deter-
mine whether the failure of wt SV5 (W3) to induce IFN-
expression could be linked to a defect in activation of
one of these factors or the failure to activate several
transcription factors, we transiently transfected a series
of luciferase reporter constructs under the control of the
human IFN- promoter and mutant derivatives and ex-
amined their inducibility by viral infection. The constructs
used in this analysis are shown in Fig. 3A. Figure 3B
shows that deletion from the 5 end of the IFN- pro-
moter had only a limited effect on induction by rSV5VC
until nucleotide 98 was removed; these results dem-
onstrate that the HMGI:Y binding sequence (TAAAT) lo-
cated at residues 102 to 98 (Du et al., 1993) is not
required for induction of IFN- by rSV5VC, in agree-
ment with our previous observations on induction by
poly(I)poly(C) (Ellis and Goodbourn, 1994; King and
Goodbourn, 1994). Further deletion from the 5 end of the
IFN- promoter led to a stepwise loss in inducibility with
removal of the PRD III, PRD I, and PRD II elements. None
of these constructs were responsive to wt SV5 (W3)
infection (data not shown). To evaluate the individual
contribution of the PRD elements, we examined the in-
ducibility of reporter constructs under the control of the
IFN- promoter containing linker scan mutations. Figure
3B shows that disruption of any of the four PRD elements
severely impairs induction by rSV5VC. Since each of
the individual PRD elements has been shown to be
independently inducible in certain cell/inducer combina-
tions, we tested the responsiveness of reporter con-
structs containing multimers of either PRD IV, PRD III/
PRD I, or PRD II placed upstream of a minimal HSV-1
thymidine kinase TATA box. Figure 3C shows that the
NF-B-responsive PRD II construct and the IRF-respon-
sive PRD I/PRD III construct respond dramatically to
infection by rSV5VC, whereas expression driven by the
PRD IV construct is not responsive. Taken together, the
insensitivity to deletion of the HMGI:Y site between103
and 97 and the lack of inducibility of the PRD IV re-
porter construct demonstrate that activation of the ATF-
2-c-Jun/HMGI:Y module (Du and Maniatis, 1992; Du et al.,
1993) is unimportant for IFN- induction by rSV5VC,
and we have not considered it further.
In contrast to the induction of both the PRD II and the
PRD I/III reporters by rSV5VC, neither reporter is acti-
vated by wt SV5 (W3) infection (Fig. 3C), suggesting that
infection by wt SV5 (W3) virus fails to activate a signaling
pathway that is common to the induction of factors that
stimulate transcription through the unrelated PRD II and
PRD I/III elements. Consistent with this, the overexpres-
sion of the SV5 V protein significantly diminishes the
induction of both reporters by rSV5VC (Fig. 3C).
Although the PRD I/III site of the IFN- promoter can
bind to several members of the IRF family, it is believed
that IRF-3 activation plays a key role in IFN- induction in
response to viral infection (see Introduction). To test
whether IRF-3 activation plays a role in IFN- induction
by rSV5VC, we examined the effect of expressing a
dominant-interfering form of IRF-3 (Lin et al., 1998). Fig-
ure 3D shows that induction by rSV5VC is completely
abolished in the presence of the interfering form of IRF-3.
To examine the behavior of IRF-3 in isolation from other
members of the IRF family, we constructed a fusion to the
bacterial DNA-binding protein, lexA, and examined the
ability of this fusion to stimulate transcription from a
luciferase reporter gene under the control of a lexA
operator site. Figure 3E shows that this construct is
responsive to infection by rSV5VC [but not by infection
by wt SV5 (W3)—data not shown]. The induction in
response to rSV5VC is significantly inhibited by the
coexpression of the SV5 V protein (Fig. 3E). These data
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show that IRF-3 activation is required for IFN- induction
by rSV5VC and that the activation of IRF-3 can be
blocked by the SV5 V protein.
The data above suggest that NF-B and IRF-3 are the
key transcription factors involved in IFN- induction in
response to rSV5VC infection; these factors are not
induced in the presence of the full-length V protein ex-
pressed during either a wild-type infection or expressed
in trans during infection by rSV5VC. We have confirmed
the activation of both NF-B and IRF-3 by rSV5VC in-
fection, but not wt SV5 (W3) infection, by gel-retardation
assays and immunofluorescence experiments; also note
that rSV5VC infection leads (indirectly) to IRF-1 produc-
tion and ISGF3 activation (He et al., 2002 and data not
shown). The failure of wt SV5 (W3) infection to activate
these responses could be due to a virally induced deg-
radation of transcription factors in a manner analogous
to the degradation of STAT1. Western blot analysis using
antibodies specific for either the p65 or the p50 subunits
of NF-B subunit, or for IRF-3, demonstrated that neither
of these proteins are targeted for degradation by SV5
infection, in contrast to the consequences of SV5 infec-
tion on STAT1 (Fig. 4).
The V protein of SV5 can block the induction of IFN-
by dsRNA
The difference in the IFN-inducing properties of wild-
type SV5 (W3) and rSV5VC could be due either to the V
product having a specific function that directly blocks
IFN- production or to an indirect effect such that the
viruses have different innate IFN inducing capacities; for
example, rSV5VC infections could generate more intra-
cellular dsRNA than wt SV5 (W3). To distinguish these
possibilities, we investigated whether overexpression of
the SV5 V protein could block induction by synthetic
dsRNA of a luciferase reporter gene under the control of
an intact IFN- promoter in transient transfections. Fig-
ure 5A shows that SV5 V protein expression can limit
induction of the IFN- promoter by about 90%; we per-
formed similar experiments in 293 cells and obtained a
similar inhibition of IFN- induction by the SV5 V protein
(Fig. 5B). In addition to the ability of the SV5 V protein to
block dsRNA induction of the IFN- promoter, blockage
was also seen in response to Sendai virus infection (Fig.
5C). Since dsRNA can activate individual transcription
factors that are involved in IFN- induction, we examined
the ability of the SV5 V protein to block NF-B induction
by dsRNA. Figure 5D shows that the induction of reporter
activity by dsRNA is down-regulated by about 80% when
FIG. 3. NF-B and IRF-3 are required for IFN- induction by rSV5VC. (A) Reporter gene constructs. The architecture of the IFN- promoter is
indicated at the top of the panel and described in the text. The 5 deletion series is shown in the left panel; the bottom four constructs are the linker
scan mutations which are all based on the 116 deletion but which have an 8–10 base-pair region of the IFN- promoter replaced by a BglII linker
(lower case). Each linker scan mutation inactivates one of the PRDs. The top right panel shows the construction of the individual PRD reporters; the
IFN- promoter sequences indicated are multimerized and inserted 5 to the minimal (39) TATA box of the HSV-1 thymidine kinase promoter. The
bottom right panel shows the constructs used to analyze the role of IRF-3; the reporter gene is a dimerized lex operator sequence placed upstream
of the HSV-1 thymidine kinase promoter and the effectors are either the DNA-binding domain of lexA alone (Lex-DBD) or the DNA-binding domain
of lexA fused to IRF-3 (Lex-IRF-3). (B) Vero cells were transfected with the indicated reporter and the -galactosidase expression vector, pJATlac, and
subsequently mock-infected or infected with rSV5VC (VC) at an m.o.i. of 5 for 18 h. Expression levels are relative to the rSV5VC-infected level
of the 125 construct (1.0). (C) Vero cells were transfected with the indicated reporter, pJATlac, and either a mammalian expression plasmid driving
the overexpression of the SV5 V protein or a control empty vector, and subsequently mock-infected or infected with SV5 (W3) or rSV5VC (VC) at
an m.o.i. of 5 for 18 h. Expression levels are relative to the mock-infected level of the TK TATA box only construct (1.0). (D) Vero cells were transfected
with pIF(125), pJATlac, and either a mammalian expression plasmid driving the overexpression of the C-terminus of IRF-3 (amino acids 132–427;
IRF-3C-t) or the control empty vector and subsequently mock-infected or infected with rSV5VC (VC) at an m.o.i. of 5 for 18 h. Expression levels are
relative to the rSV5VC-infected level of the 125 construct (1.0). (E) Vero cells were transfected with the lexA-responsive luciferase reporter,
p(lexOP)2TKLuc, pJATlac, a mammalian expression plasmid driving the overexpression of either the DNA binding domain (DBD) of lexA or the fusion
between the lexA DBD, and IRF-3, and a mammalian expression plasmid driving the overexpression of the SV5 V protein or the control empty vector,
and subsequently mock-infected or infected with rSV5VC (VC) at an m.o.i. of 5 for 18 h. Expression levels are relative to the mock-infected level
of the lex DBD construct (1.0). For each of (B) to (E) luciferase and -galactosidase activities were determined from cellular extracts and relative
expression values calculated accordingly. Transfection experiments were repeated at least three times and averages with error bars are shown.
FIG. 4. STAT1, but not NF-B subunits or IRF-3, is degraded by SV5
(W3) infection. MG-63 cells were infected with either SV5 (W3) or
rSV5VC (VC) at an m.o.i. of 5 and incubated for the indicated times,
and cell extracts were analyzed by Western blotting using antisera
specific for p65, p50, IRF-3, STAT1, or the P protein of SV5.
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cells were cotransfected with the SV5 V protein express-
ing plasmid; by contrast, we observed a small but repro-
ducible enhancement of induction by an alternative
NF-B inducer, TNF (Fig. 5E). These data indicate that
the SV5 V protein can block intracellular dsRNA signaling
in the absence of other viral products.
Inhibition of induction of IFN- by SV5 V protein is a
property of the cysteine-rich C-terminus
To map the regions of the SV5 V protein that block the
induction of IFN- by synthetic dsRNA, we first deter-
mined whether the viral polymerase P protein had similar
properties, as the V and P proteins share 164 N-terminal
residues. As shown in Fig. 6A the SV5 P protein is unable
to block the induction of IFN- by synthetic dsRNA. Thus,
these data indicate that the unique cysteine-rich C-ter-
minus of V plays an important role in this process.
A panel of mutations in the SV5 V gene was con-
structed and the effect of expression of these proteins on
IFN- induction by dsRNA was examined. As shown in
Fig. 6B deletion of N-terminal sequences up to amino
acid 125 had no effect on inhibition. Deletion of the
C-terminal 48 amino acids inactivated the inhibition, in-
dicating that the C-terminal region of the protein is im-
portant for blocking IFN- induction, in contrast to the
block to IFN signaling which requires sequences at the
N-terminus as well as the C-terminus (Young et al., 2001;
Chatziandreou et al., 2002; Andrejeva et al., in press).
The C-terminal region of the SV5 V protein is charac-
terized by the presence of several cysteine residues. To
investigate the importance of these cysteine residues in
blocking IFN- induction, we changed several of them by
site-directed mutagenesis, cloned the mutant genes into
a mammalian expression vector, and then examined
their effects in response to synthetic dsRNA. As shown in
Fig. 6C changes at cysteines 193, 207, and 214 individu-
ally inactivated the ability of the viral V protein to block
dsRNA signaling, despite the proteins being expressed
at equivalent levels as assessed by immunofluores-
cence (data not shown). These data show that inhibition
of induction of IFN- requires a cysteine-rich region of no
more than 97 amino acids (amino acids 126 to 222) at the
C-terminal end of the SV5 V protein.
Inhibition of induction of IFN- is a property of other
paramyxovirus V proteins
The importance of the cysteine-rich C-terminus of SV5
in blocking the induction of IFN- is particularly interest-
ing since this region is the most conserved domain
among V proteins of other Paramyxovirinae, including
viruses from all three genera, Respiroviruses, Rubulavi-
ruses, and Morbilliviruses. To investigate whether V pro-
teins from viruses other than SV5 could block IFN-
induction, we constructed mammalian expression vec-
tors for the V proteins of hPIV2 and Sendai virus. Both of
these constructs blocked IFN- induction by dsRNA to
FIG. 5. The V protein of SV5 can block signaling in response to dsRNA. (A) Vero cells were transfected with pIF(125)lucter, pJATlac, and either
a mammalian expression plasmid driving the overexpression of the SV5 V protein or the control empty vector. Transfected cells were either
mock-treated or treated with poly(I)-poly(C) (dsRNA) and cell extracts prepared. (B). Experiments were performed identically to (A) except that 293 cells
were used. (C). Experiments were performed identically to (A) except that Sendai virus (vM3 preparation) was used as an inducer instead of dsRNA.
(D). Vero cells were transfected with a reporter for NF-B activity [p(PRD II)5tk(-39)lucter], pJATlac, and either a mammalian expression plasmid
driving the overexpression of the SV5 V protein or the control empty vector. Transfected cells were either mock-treated or treated with poly(I)-poly(C)
(dsRNA) and cell extracts prepared. (E) Experiments were performed identically to (D) except that TNF was used as an inducer of NF-B instead
of dsRNA. For each of (A)–(E) luciferase and -galactosidase activities were determined from cellular extracts and relative expression values
calculated accordingly (expressed relative to the induced level of the vector-only sample 1.0). Transfection experiments were repeated at least three
times and averages with error bars are shown.
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an equivalent extent to the V protein of wt SV5 (W3) (Fig.
7). We also examined the properties of V proteins of
distinct isolates of SV5. Figure 7 shows that an N100D
change (from a virulent mouse-adapted strain) (Young et
al., 2001), and the limited substitutions observed in the
CPI and CPI strains (Chatziandreou et al., 2002) had
no effect on the blockage to IFN- induction by dsRNA;
these results were expected since these amino acid
changes lie outside of the conserved cysteine-rich C-
terminus.
DISCUSSION
We have reported previously that the V protein of SV5
plays an essential role in evading the IFN system by
targeting the host cells STAT1 protein for proteosomal
degradation (Didcock et al., 1999b). Similar results have
been reported for the V protein of hPIV2, except that
STAT2 is preferentially degraded (Parisien et al., 2001;
Nishio et al., 2001; Andrejeva et al., 2002). In this article,
we show that the V protein of SV5 has an additional
distinct effect on the IFN system, namely that of acting to
minimize the yield of IFN- produced by an infected cell.
While this property is dispensable for growth in Vero
cells that cannot produce IFN, it appears to be essential
for efficient growth in other cell lines in which the IFN
system is intact (see He et al., 2002); consistent with this
revertants are generated at high frequency during pas-
sage of the SV5VC mutant virus. Since the SV5 V pro-
tein blocks transcriptional activation of the IFN- gene by
dsRNA, it is also probable that the direct viral activation
(i.e., through the production of dsRNA) of other genes
FIG. 6. The C-terminal cysteine-rich region of the SV5 V protein is essential for blocking dsRNA signaling. (A) Vero cells were transfected with
pIF(125)lucter, pJATlac, and either a mammalian expression plasmid driving the overexpression of SV5 V protein, a mammalian expression plasmid
driving the overexpression of SV5 P protein, or the control empty vector. Transfected cells were either mock-treated or treated with poly(I)-poly(C)
(dsRNA) and cell extracts prepared. (B) and (C) Vero cells were transfected with pIF(125)lucter, pJATlac, and either a mammalian expression
plasmid driving the overexpression of wt or mutant forms of SV5 V protein (see table at the left of figure), or the control empty vector. Transfected cells
were either mock-treated or treated with poly(I)-poly(C) (dsRNA) and cell extracts prepared. For each of (A)–(C) luciferase and -galactosidase
activities were determined from cellular extracts and relative expression values calculated accordingly (expressed relative to the induced level of the
vector-only sample  1.0). Transfection experiments were repeated at least three times and averages with error bars are shown.
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involved in the antiviral response, such as Mx, are also
blocked.
Our analysis of the V proteins of hPIV2 and Sendai
virus show that they also block induction of IFN-, and
since the domain that is required for blockage by the SV5
V protein is the C-terminal cysteine-rich domain that is
highly conserved among paramyxoviruses, we think it
likely that the ability to block IFN- production may be a
general property of paramyxovirus V proteins. Indeed,
this property may be a requirement for efficient growth in
the face of a functional IFN system. The V protein is often
described as a “luxury function” in that it is not required
for growth in culture for rinderpest (Baron and Barrett,
2000), Sendai virus (Delenda et al., 1997, 1998), or mea-
sles virus (Schneider et al., 1997). Nevertheless, patho-
genicity has been shown to be impaired for Sendai virus
(Kato et al., 1997a,b; Huang et al., 2000) or measles virus
(Tober et al., 1998; Valsamatis et al., 1998; Mrkic et al.,
2000; Patterson et al., 2000) lacking an intact V protein
and we speculate that this is at least in part due to the
loss of ability to block IFN production. It is interesting to
note that measles virus has been shown to block IFN
production (Naniche et al., 2000), although this property
has yet to be ascribed to the V protein.
Although the V proteins of the Rubulaviruses have the
ability to block both the induction of IFN and the down-
stream signaling in response to IFN, this function has
been separated in the Respirovirus, Sendai virus (Garcin
et al., 1999; reviewed in Gotoh et al., 2001). Thus the C
protein(s) of Sendai virus is responsible for blocking IFN
signaling, while the V protein blocks IFN induction. Nev-
ertheless, the fact that both Rubulavirus and Respirovirus
genera of paramyxoviruses have acquired the ability to
block both arms of the IFN system demonstrates the
importance of avoiding this aspect of innate immunity to
establish a productive infection. It should be emphasized
that the blocks are probably operating at different stages
during the course of an infection. We have shown previ-
ously that although SV5 can degrade the antiviral state
established in a cell by previous exposure to IFN (Did-
cock et al., 1999b), this process takes several hours and
hence the rate of viral spread would be much enhanced
if IFN production was limited during the first round of
viral infection.
The role of the V protein in limiting the yield of IFN
could act in two fundamentally distinct ways. First, it
could act to limit the generation of an inducer produced
during the viral lifecycle. Second, the V protein could act
to prevent the downstream action of a virally generated
inducer. Since the V protein can inhibit the signaling
response to synthetic dsRNA in activating NF-B, this
second role for the V protein would appear to be of major
importance. However, we are struck by our observation
that none of the paramyxovirus V proteins we have ex-
amined are capable of inhibiting the induction of IFN-
by dsRNA more than 80–90%. This contrasts with the
extremely limited induction of IFN- in the context of viral
infection, where wt SV5 (W3) (which expresses a wt V
protein) barely induces IFN- in any cell line tested (less
than 1% of the levels seen in rSV5VC infections),
strongly suggesting that a function of the V protein (e.g.,
in the control of transcription or replication—see below)
also limits the generation of the viral inducer of IFN. This
is consistent with our observations that inhibition of
dsRNA signaling requires significant levels of V protein
expression that might only be achieved relatively late in
viral infection and perhaps after the start of generation of
the viral signal.
This virally induced signal could be dsRNA, produced
during the viral lifecycle. It is well established that V
proteins help to regulate viral replication. Sendai virus
deficient in V protein synthesis shows increased anti-
genome synthesis and transcription (Kato et al., 1997a),
and expression of the V protein decreased replication by
60–70% in a Sendai virus DI RNA assay (Curran et al.,
1991), suggesting that V protein may negatively regulate
viral replication. Studies on rinderpest virus lacking ex-
pression of the V protein show a rise in synthesis of
genome and antigenome RNAs, as well as an increase in
the cytopathic effect (Baron and Barrett, 2000). Although
a role for the SV5 V protein in regulating RNA replication
has not been shown, the SV5 V protein is known to have
many functions. The shared N-terminal domain of V and
P proteins binds single-stranded RNA through a basic
region (Lin et al., 1997) and the SV5 V protein interacts
with soluble but not polymeric NP protein and thus may
FIG. 7. The V proteins of other paramyxoviruses block dsRNA sig-
naling. Vero cells were transfected with pIF(125)lucter, pJATlac, and
either a mammalian expression plasmid driving the overexpression of
the V protein of the indicated paramyxovirus or the control empty
vector. Transfected cells were either mock-treated or treated with
poly(I)-poly(C) (dsRNA) and cell extracts prepared. Luciferase and -ga-
lactosidase activities were determined from cellular extracts and rela-
tive expression values calculated accordingly (expressed relative to the
induced level of the vector-only sample  1.0). Transfection experi-
ments were repeated at least three times and averages with error bars
are shown.
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act as a chaperone to keep NP soluble prior to encap-
sidation of vRNA (Randall and Bermingham, 1996). Taken
together these observations suggest that the V protein
may perhaps indirectly limit viral dsRNA levels. It is also
possible that the virally induced signal could be some
component of the viral lifecycle other than dsRNA. In this
context, a recent article suggesting that the measles N
gene product can function as an activator of IRF-3
(tenOever et al., 2002) is particularly interesting. The
interaction of SV5 V protein with NP might inhibit an
equivalent activation by IRF-3.
The target for the V protein in blocking dsRNA signal-
ing is not known. An obvious target would be the dsRNA-
dependent protein kinase, PKR. This enzyme has been
shown to be important for the activation of NF-B by
dsRNA (Yang et al., 1995; Kumar et al., 1997), although
recent results suggest that there is a second PKR-inde-
pendent pathway (Abraham et al., 1999; Iordanov et al.,
2000a). Our observation that the V protein cannot block
dsRNA signaling completely may reflect expression lev-
els, or it may reflect the possibility that the V protein can
only block one of the alternative dsRNA signaling path-
ways. It is also unclear whether PKR can function as an
upstream kinase for IRF-3 activation; although IRF-3 nu-
clear translocation in response to either Sendai virus or
NDV is not dependent upon PKR (Servant et al., 2001;
Smith et al., 2001), it is not clear whether PKR can
perform this function in a redundant pathway. Since the
SV5 V protein can block activation of both NF-B and
IRF-3, it promises to be a useful reagent for analyzing
signaling events that occur during paramyxovirus and
other viral infections.
MATERIALS AND METHODS
Plasmids
The reporter plasmids with the firefly luciferase
gene under the control of the human IFN- promo-
ter, pIF(125)lucter and the 5 deletion mutants,
pIF(116)lucter, pIF(103)lucter, pIF(98)lucter,
pIF(97)lucter, pIF(92)lucter, pIF(82)lucter,
pIF(78)lucter, and pIF(70)lucter have been pre-
viously described (King and Goodbourn, 1994). The
linker scan mutants were constructed by generating a
series of 3 deletion mutants flanked by BglII linkers
starting from the NcoI site in the human IFN- pro-
moter of pIF(116)lucter at 12 using the method of
King and Goodbourn (1992). These mutants were char-
acterized by sequencing and then recombined via
their BglII linkers with the appropriate 5 deletion
mutants from our extensive collection (King and Good-
bourn, 1992). The synthetic PRD multimer reporters, p(PRD
IV)3tk(39)lucter, p(PRD I/PRD III)5tk(39)lucter and
p(PRD II)5tk(39)lucter, the IFN-responsive ISRE reporter
p(9–27ISRE)4tk(39)lucter, and the TK TATA only reporter,
ptk(39)lucter, have been previously described (Vis-
vanathan and Goodbourn, 1989; King and Goodbourn, 1994,
1998) as has the constitutive -galactosidase transfection
control reporter plasmid, pJATlac (Masson et al., 1992). The
lex-responsive luciferase reporter, p(lexOP)2TK(105)luc,
was a kind gift of Dr. Richard Treisman (Cancer Research,
U.K.).
All expression in mammalian cells was achieved by
subcloning into pEF.plink2 (Dr. Richard Treisman, Cancer
Research, U.K.), a vector in which the test transcript is
placed under the control of the mammalian EF1 pro-
moter. The plasmids directing the expression of the V or
P proteins of SV5, pEF.SV5-V, and pEF.SV5-P have been
previously described (Didcock et al., 1999b). Equivalent
plasmids expressing the V genes of hPIV2, CPI, CPI,
mci-2 (Young et al., 2001), and Sendai virus were ob-
tained using the same strategy [plasmids pEF.hPIV2-V,
pEF.SV5-V(CPI), pEF.SV5-V(CPI), pEF.SV5-V(mci-2),
and pEF.SeV-V, respectively]. pEF plasmids directing
the expression of C-terminal truncations of SV5 V protein
were obtained by cloning NcoI-PstI (amino acids 1–56;
pEF.SV5-V[1–56]), NcoI-ClaI (amino acids 1–157;
pEF.SV5-V[1–157]), or NcoI-ScaI (amino acids 1–174;
pEF.SV5-V[1–174]) fragments between the NcoI site and a
filled-in EcoRI site of pEFplink2. pEF plasmids directing
the expression of N-terminal truncations of SV5 V protein
were obtained by cloning PCR-amplified fragments (in-
corporating NcoI and EcoRI sites into the 5 and 3 ends,
respectively, of the SV5 V fragment) directly between the
NcoI and EcoRI sites of pEFplink2 to generate pEF.SV5-
V[20–222] (amino acids 20–222), pEF.SV5-V[85–222]
(amino acids 85–222), and pEF.SV5-V[104–222] (amino
acids 104–222). Point mutants were introduced into
pEF.SV5-V using recombinant PCR to create pEF.SV5-
V[C193A], pEF.SV5-V[C207A], and pEF.SV5-V[C214A]. All
V mutated genes were sequenced (Lark Technologies)
and a double-mutant pEF.SV5-V[C193Y/C214A] was ob-
tained as a by-product of one of the mutagenesis exper-
iments. The lexA DBD vector, pEF.mlexA, was con-
structed by recombinant PCR so as to obtain a DNA-
binding-domain fragment (amino acids 1 to 202) of the
bacterial lexA transcription factor containing a mutation
in the cryptic nuclear localization sequence (Rhee et al.,
2000) and inserted into the NcoI site of pEF.plink2. The
full-length ORF of IRF-3 flanked by NcoI (5) and XbaI (3)
sites was obtained from MG-63 osteosarcoma cells by
RT-PCR and was cloned in-frame to the lexA DBD of
pEF.mlexA to give pEF.mlexA.IRF-3. The full-length cDNA
of IRF-3 was also used to generate the C-terminal dom-
inant interfering form of IRF-3 by subcloning the ScaI-
XbaI fragment in-frame with the polylinker of pEF.plink2
to give pEF.IRF-3(132–427).
Viruses and cells
The W3 strain of SV5 (Choppin, 1964), rSV5VC (see
accompanying article, He et al., 2002), N100D (Young et
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al., 2001), and canine parainfluenza virus strains, CPI
and CPI (Chatziandreou et al., 2002), were propagated
and titered in Vero cells. Sendai virus (strain Z) and NDV
(Ulster 2c strain) were a kind gift from Dr. J. W. McCauley
(Institute of Animal Health, Compton, U.K.) and were
prepared by inoculation of 10-day-old embryonated
chickens eggs with a high dilution of viral stock, followed
by 48 h incubation at 35°C. The efficient IFN- inducer
stock of Sendai virus used in Fig. 1A was prepared by
three serial passages of the above Sendai virus stock at
a 1:10 dilution each passage (von Magnus, 1951a,b). Viral
titers for Sendai virus and NDV were established by
egg-infectious dose.
MG-63 human osteosarcoma cells (ATCC CRL 1427),
human diploid fibroblast 2fTGH cells (Pelligrini et al.,
1989), 2fTGH/V cells (Andrejeva et al., 2002), 293 trans-
formed primary human embryonic kidney cells (ATCC
CRL 1573), and mouse BALB/c cells (ATCC CCL 163)
were maintained in Dulbecco’s modified Eagle’s medium
(Biowhittaker Europe) supplemented with 10% fetal bo-
vine serum (FBS; Invitrogen) and 100 U/ml penicillin/
streptomycin and were routinely screened for myco-
plasma contamination.
Inductions
Six-well dishes containing in excess of 106 cells per
well (determined by trypan blue exclusion) were washed
twice with PBS and then inoculated with virus at the
given multiplicity of infection in 1 ml of DME  2% FBS.
Cells were incubated with gentle rocking for 1 h at 37°C
and then the virus was removed and the medium re-
placed with 5 ml DME  2% FBS until harvesting. Cells
were either harvested for RNA analysis by acid-phenol/
guanidinium isothiocyanate extraction or were scraped
into 1 ml ice-cold PBS and pelleted for nuclear extract
preparation. For induction by synthetic dsRNA, poly(I)-
poly(C) (Amersham Biosciences) was either added di-
rectly to cells at a final concentration of 100 g/ml or was
transfected into cells using Lipofectamine (Invitrogen)
under conditions specified by the manufacturer. TNF
(Preprotech) was added to cells at 10 ng/ml. Type I IFN
(Intron A; Schering-Plough) was added to cells at 1000
IU/ml.
Protein analysis
To analyze protein levels by Western blotting, cells
were washed twice with PBS, disrupted into Laemmli’s
loading buffer, sonicated, and boiled for 5 min. Polypep-
tides were separated by SDS–PAGE using 10% gels and
transferred to PVDF membranes using semidry blotting.
Filters were blocked and incubated with primary anti-
body under conditions specified by the manufacturers,
and proteins detected by enhanced chemiluminescence
using horseradish peroxidase conjugated sheep anti-
mouse or donkey anti-rabbit IgG (Amersham Bio-
sciences) as secondary antibodies. Primary antibodies
used were as follows: SV5 P/V protein–anti-Pk mAb (Ran-
dall et al., 1987); p65 and p50 (Mellits et al., 1993); IRF-3
(Santa Cruz Biotechnology, Inc., catalog number
sc-9082); STAT1 mAb (Transduction Laboratories, cata-
log number G16920).
Analysis of gene expression
Total cellular RNA was prepared using the acid phenol
method from 9-cm-diameter dishes of confluent cultures
of cells treated as indicated and analyzed by RNase
protection as described previously using probes for hu-
man IFN- and -actin (Goodbourn et al., 1986). For
reporter gene assays, lysates were prepared and ana-
lyzed for luciferase and -galactosidase activity as pre-
viously described (King and Goodbourn, 1994).
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